University of Sussex
Browse
HLA-DRB1 15 influences the development of brain tissue damage in early PPMS.pdf (497.71 kB)

HLA-DRB1*15 influences the development of brain tissue damage in early PPMS

Download (497.71 kB)
journal contribution
posted on 2023-06-09, 09:29 authored by Carmen Tur, Sreeram Ramagopalan, Daniel R Altmann, Benedetta Bodini, Mara Cercignani, Zhaleh Khaleeli, David H Miller, Alan J Thompson, Olga Ciccarelli
OBJECTIVES To investigate whether (1) there were differences between HLA-DRB1*15-positive and -negative patients at baseline, and (2) HLA-DRB1*15-positive patients showed a greater development of brain and spinal cord damage, as assessed by MRI, and greater progression of disability, during a 5-year follow-up, compared with HLA-DRB1*15-negative patients. METHODS HLA-DRB1*15 typing was performed in 41 patients with primary progressive multiple sclerosis (PPMS) who were recruited within 5 years of symptom onset. All patients and 18 healthy controls were studied clinically and with MRI at baseline, and every 6 months for 3 years, and then at 5 years. Magnetization transfer ratio parameters and volumes for brain gray matter and normal-appearing white matter, brain T2 lesion load, and spinal cord cross-sectional area were obtained. Patient disability was assessed at each visit using the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite subscores. RESULTS There were no significant differences between HLA-DRB1*15-positive and -negative patients at baseline. HLA-DRB1*15-positive patients showed a greater decline in brain magnetization transfer ratio for gray matter and normal-appearing white matter (both p = 0.005) than HLA-DRB1*15-negative patients over 5 years, while the same parameters did not change over time in healthy controls. HLA-DRB1*15-positive patients also showed a trend toward a faster increase in brain T2 lesion load than HLA-DRB1*15-negative patients (0.29 [95% confidence interval 0.20-0.38] vs 0.21 [0.13-0.30] mL/mo, p = 0.085) and higher T2 lesion volumes at all time points (average difference [95% confidence interval]: 10.58 mL [7.09-14.07], p < 0.001) during the follow-up, after adjusting for disease duration. CONCLUSIONS These findings suggest that HLA-DRB1*15 influences the progression of brain pathology in PPMS.

History

Publication status

  • Published

File Version

  • Accepted version

Journal

Neurology

ISSN

1526-632X

Publisher

American Academy of Neurology

Issue

19

Volume

83

Department affiliated with

  • BSMS Neuroscience Publications

Full text available

  • Yes

Peer reviewed?

  • Yes

Legacy Posted Date

2019-12-06

First Open Access (FOA) Date

2019-12-11

First Compliant Deposit (FCD) Date

2019-12-11

Usage metrics

    University of Sussex (Publications)

    Categories

    No categories selected

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC